摘要
目的探讨生脉注射液辅治慢性阻塞性肺疾病的临床疗效。方法将60例慢性阻塞性肺疾病患者随机分为治疗组和对照组各30例。对照组给予氧疗、抗炎、平喘、解痉、止咳化痰等常规治疗,治疗组在对照组基础上加用生脉注射液治疗。比较2组临床疗效。结果治疗组总有效率为93.3%高于对照组的73.3%,差异有统计学意义(P<0.05)。结论生脉注射液辅治慢性阻塞性肺疾病效果较好,值得临床推广应用。
Objective To explore the clinical efficacy of Shengmai injection in the treatment of chronic obstructive pulmonary disease. Methods 60 cases patients with chronic obstructive pulmonary disease were randomly divided into treat- ment group and control group, each of 30 cases. Control group were given conventional therapy, such as oxygen therapy, anti-in- flammatory, preventing asthma, spasmolysis, relieving cough and so on. Treatment group were given Shengmai injection on the basis of control group. After treatment,compared the clinical efficacy of 2 groups. Results The total effective rate of treatment group （ 93.3 % ） was higher than that of contral group （ 73.3 % ）, the difference was statistically significant （ P 〈 0.05 ）. Conclu- sion Shengmai injection is more effective than convention treatment alone in the treatment of chronic obstructive pulmonary disease, it is worthy of further clinical and application.
出处
《临床合理用药杂志》
2013年第7期18-19,共2页
Chinese Journal of Clinical Rational Drug Use
关键词
肺疾病
慢性
阻塞性
生脉注射液
Pulmonary disease, chronic, obstructive
Shengmai injection
